China Resources Pharmaceutical Group Ltd. (3320) Income Statement

4 Followers

China Resources Pharmaceutical Group Ltd. Income Statement

Last quarter (Q4 2025), China Resources Pharmaceutical Group Ltd.'s total revenue was HK$150.76B, an increase of 12.43% from the same quarter last year. In Q4, China Resources Pharmaceutical Group Ltd.'s net income was HK$2.15B. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 292.36B	HK$ 274.18B	HK$ 270.40B	HK$ 254.11B	HK$ 236.81B
Gross Profit	HK$ 48.27B	HK$ 43.30B	HK$ 42.18B	HK$ 39.13B	HK$ 35.38B
Operating Expenses	HK$ 34.84B	HK$ 30.73B	HK$ 30.52B	HK$ 28.32B	HK$ 26.13B
Depreciation and Amortization	HK$ 4.43B	HK$ 2.70B	HK$ 3.16B	HK$ 3.15B	HK$ 2.82B
EBITDA	HK$ 17.85B	HK$ 15.45B	HK$ 15.43B	HK$ 15.47B	HK$ 11.95B
Operating Income	HK$ 13.43B	HK$ 12.90B	HK$ 11.66B	HK$ 10.81B	HK$ 9.25B
Other Income/Expenses	HK$ -634.53M	HK$ -1.27B	HK$ -786.72M	HK$ -956.77M	HK$ -840.41M
Pretax Income	HK$ 12.79B	HK$ 11.63B	HK$ 10.87B	HK$ 9.86B	HK$ 8.41B
Net Income	HK$ 4.39B	HK$ 3.57B	HK$ 3.85B	HK$ 3.50B	HK$ 3.08B
Per Share Metrics
Basic EPS	HK$ 0.70	HK$ 0.56	HK$ 0.68	HK$ 0.66	HK$ 0.60
Diluted EPS	HK$ 0.70	HK$ 0.56	HK$ 0.68	HK$ 0.66	HK$ 0.60
Weighted Average Shares Outstanding	6.28B	6.28B	6.28B	6.28B	6.28B
Weighted Average Shares Outstanding (Diluted)	6.28B	6.28B	6.28B	6.28B	6.28B

Currency in HKD

China Resources Pharmaceutical Group Ltd. (3320) Income Statement

China Resources Pharmaceutical Group Ltd. Income Statement

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History